MedTrace Logo

Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes Mellitus

NCT06202742 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-03-15

No results posted yet for this study

Summary

This study will explore the effects of cognitive behavioral therapy for insomnia (CBTI) compare to health educations in patients with type 2 diabetes (T2DM) with insomnia symptoms.

Conditions

Interventions

BEHAVIORAL

cognitive behavioral therapy for insomnia

Online meeting, weekly for 8 weeks, to deliver CBTI by psychologist/ psychiatrist

BEHAVIORAL

Health education

Online meeting, weekly for 8 weeks, to deliver general health knowledge

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Similan Kirisri · Ramathibodi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-08
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06202742 on ClinicalTrials.gov